N3,N3,N7,N7-四甲基-10H-吩噻嗪-3,7-二胺二甲磺酸盐

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并噻嗪类
• 中文名称: N3,N3,N7,N7-四甲基-10H-吩噻嗪-3,7-二胺二甲磺酸盐
• 英文名称: TRx0237 (LMTX) mesylate
• 英文别名: [7-(dimethylazaniumyl)-10H-phenothiazin-3-yl]-dimethylazanium;methanesulfonate
• 化学式: C18H27N3O6S3
• 分子量: 477.6
• InChiKey: SPCMQFLNOVTUBM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.03
• 重原子数：
  30
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  169
• 氢给体数：
  3
• 氢受体数：
  10

文献信息

• PHENOTHIAZINE DIAMINIUM SALTS AND THEIR USE
  申请人：Clunas Scott

  公开号：US20130315992A1

  公开（公告）日：2013-11-28

  The invention relates to compounds of general formula (I): wherein: each of R 1 and R 9 is independently selected from: —H, C 1-4 alkyl, C 2-4 alkenyl, and halogenated C 1-4 alkyl; each of R 3NA and R 3NB is independently selected from: —H, C 1-4 alkyl, C 2-4 alkenyl, and halogenated C 1-4 alkyl; each of R7NA and R7NB is independently selected from: —H, C 1-4 alkyl, C 2-4 alkenyl, and halogenated C 1-4 alkyl; and wherein: each of R A and R B is independently selected from: C 1-4 alkyl, halogenated C 1-4 alkyl, and C 6-10 aryl; or R A and R B are linked to form a group selected from: C 1-6 alkylene and C 6-10 arylene; and pharmaceutically acceptable salts thereof, which are useful in the treatment of, for example, Alzheimer's disease. In other aspects the invention also relates to novel formulations of 3,7-diamino-10H-phenothiazinium salts.

  该发明涉及通式（I）的化合物：其中：R1和R9各自独立地选自：—H，C1-4烷基，C2-4烯基和卤代C1-4烷基；R3NA和R3NB各自独立地选自：—H，C1-4烷基，C2-4烯基和卤代C1-4烷基；R7NA和R7NB各自独立地选自：—H，C1-4烷基，C2-4烯基和卤代C1-4烷基；其中：RA和RB各自独立地选自：C1-4烷基，卤代C1-4烷基和C6-10芳基；或RA和RB连接形成所选的基团，所选的基团选自：C1-6烷基和C6-10芳基；以及其药学上可接受的盐，其在例如阿尔茨海默病的治疗中有用。在其他方面，该发明还涉及3,7-二氨基-10H-苯并噻吩盐的新配方。
• Methods of chemical synthesis of substituted 10H-phenothiazine-3,7-diamine compounds
  申请人：WisTa Laboratories Ltd.

  公开号：US10323010B2

  公开（公告）日：2019-06-18

  The present invention pertains generally to the field of chemical synthesis, and more particularly to methods of chemical synthesis which include the step of preparing a substituted 10H-phenothiazine-3,7-diamine compound of Formula (1) by a step of selective alkylation by reductive amination, in which the corresponding unsubstituted diamine of Formula (4) is reacted with aldehyde/ketone, under reductive amination conditions. The present invention also relates to such methods which incorporate additional subsequent and/or preceding steps, for example, to prepare compounds of Formulae (2) and (3) from compounds of Formula (1), and to prepare compounds of Formula (4) from, for example, compounds of Formulae (5), (6), (7), (8), and (9). Compounds of Formula (1), Formula (2), and Formula (3) are useful, for example, in the treatment of diseases of protein aggregation, such as Alzheimer's disease.

  本发明一般涉及化学合成领域，更具体地说，涉及化学合成方法，其中包括通过还原胺化选择性烷基化步骤制备取代的式(1)10H-吩噻嗪-3,7-二胺化合物，在还原胺化条件下，相应的式(4)未取代二胺与醛/酮反应。本发明还涉及包含额外后续步骤和/或前述步骤的此类方法，例如，由式（1）化合物制备式（2）和（3）化合物，以及由式（5）、（6）、（7）、（8）和（9）化合物制备式（4）化合物。式（1）、式（2）和式（3）化合物可用于治疗蛋白质聚集性疾病，如阿尔茨海默病。
• Phenothiazine diaminium salts and their use
  申请人：WisTa Laboratories Ltd.

  公开号：US10864216B2

  公开（公告）日：2020-12-15

  Disclosed are compounds of general formula (I): and pharmaceutically acceptable salts thereof, formulations, methods and uses in, for example, the treatment of disease.

  公开了通式 (I) 的化合物：及其药学上可接受的盐、制剂、方法和用途，例如在疾病治疗中的应用。
• METHODS OF CHEMICAL SYNTHESIS OF SUBSTITUTED 10H-PHENOTHIAZINE-3,7-DIAMINE COMPOUNDS
  申请人：WisTa Laboratories Ltd.

  公开号：US20180208565A1

  公开（公告）日：2018-07-26

  The present invention pertains generally to the field of chemical synthesis, and more particularly to methods of chemical synthesis which include the step of preparing a substituted 10H-phenothiazine-3,7-diamine compound of Formula (1) by a step of selective alkylation by reductive amination, in which the corresponding unsubstituted diamine of Formula (4) is reacted with aldehyde/ketone, under reductive amination conditions. The present invention also relates to such methods which incorporate additional subsequent and/or preceding steps, for example, to prepare compounds of Formulae (2) and (3) from compounds of Formula (1), and to prepare compounds of Formula (4) from, for example, compounds of Formulae (5), (6), (7), (8), and (9). Compounds of Formula (1), Formula (2), and Formula (3) are useful, for example, in the treatment of diseases of protein aggregation, such as Alzheimer's disease.
• US9283230B2
  申请人：——

  公开号：US9283230B2

  公开（公告）日：2016-03-15